血管内皮増殖因子(VEGF)阻害剤のグローバル市場：規模・現状・予測2019-2025

• 英文タイトル：Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9NV18526
• 出版社/出版日：QYResearch / 2019年11月18日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、91ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：医薬品・ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

※当調査レポートでは、血管内皮増殖因子(VEGF)阻害剤の世界市場について調査・分析し、血管内皮増殖因子(VEGF)阻害剤の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（VEGF-A阻害剤、VEGF-B阻害剤、VEGF-C阻害剤、VEGF-D阻害剤）、用途別（腫瘍学、眼科）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。

・レポートの概要
・世界の血管内皮増殖因子(VEGF)阻害剤市場動向
・主要企業別マーケットシェア
・血管内皮増殖因子(VEGF)阻害剤の種類別市場規模2014-2019
（VEGF-A阻害剤、VEGF-B阻害剤、VEGF-C阻害剤、VEGF-D阻害剤）
・血管内皮増殖因子(VEGF)阻害剤の用途別市場規模2014-2019
（腫瘍学、眼科）
・血管内皮増殖因子(VEGF)阻害剤の北米市場：主要企業・種類別/用途別市場規模
・血管内皮増殖因子(VEGF)阻害剤のヨーロッパ市場：主要企業・種類別/用途別市場規模
・血管内皮増殖因子(VEGF)阻害剤の中国市場：主要企業・種類別/用途別市場規模
・血管内皮増殖因子(VEGF)阻害剤の日本国内市場：主要企業・種類別/用途別市場規模
・血管内皮増殖因子(VEGF)阻害剤の東南アジア市場：主要企業・種類別/用途別市場規模
・血管内皮増殖因子(VEGF)阻害剤のインド市場：主要企業・種類別/用途別市場規模
・血管内皮増殖因子(VEGF)阻害剤の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Bayer AG、F. Hoffmann-La Roche Ltd.、Novartis AG、Regeneron Pharmaceuticals Inc.、Sanofi.）
・血管内皮増殖因子(VEGF)阻害剤の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...

Vascular endothelial growth factor inhibitors, also known as angiogenesis inhibitors, can prevent the generation of new blood vessels. The vascular endothelial growth factor is a protein that can trigger endothelial cells or pre-existing vessels to form new blood vessels. However, overexpression of vascular endothelial growth factor can generate cancerous cells.
In 2018, the global Vascular Endothelial Growth Factor (VEGF) Inhibitors market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Vascular Endothelial Growth Factor (VEGF) Inhibitors status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Vascular Endothelial Growth Factor (VEGF) Inhibitors development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Bayer AG
F. Hoffmann-La Roche Ltd.
Novartis AG
Regeneron Pharmaceuticals Inc.
Sanofi.
…

Market segment by Type, the product can be split into
VEGF-A Inhibitor
VEGF-B Inhibitor
VEGF-C Inhibitor
VEGF-D Inhibitor

Market segment by Application, split into
Oncology
Ophthalmology

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Vascular Endothelial Growth Factor (VEGF) Inhibitors status, future forecast, growth opportunity, key market and key players.
To present the Vascular Endothelial Growth Factor (VEGF) Inhibitors development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Vascular Endothelial Growth Factor (VEGF) Inhibitors are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate by Type (2014-2025)
1.4.2 VEGF-A Inhibitor
1.4.3 VEGF-B Inhibitor
1.4.4 VEGF-C Inhibitor
1.4.5 VEGF-D Inhibitor
1.5 Market by Application
1.5.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application (2019-2025)
1.5.2 Oncology
1.5.3 Ophthalmology
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size
2.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Growth Trends by Regions
2.2.1 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Regions (2019-2025)
2.2.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by by Players
3.1.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue by by Players (2014-2019)
3.1.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by by Players (2014-2019)
3.1.3 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Concentration Ratio (CR5 and HHI)
3.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Key Players Head office and Area Served
3.3 Key Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Product/Solution/Service
3.4 Date of Enter into Vascular Endothelial Growth Factor (VEGF) Inhibitors Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2014-2019)
4.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2014-2019)

5 North America
5.1 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2014-2019)
5.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Key Players in North America
5.3 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type
5.4 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application

6 Europe
6.1 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2014-2019)
6.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Key Players in Europe
6.3 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type
6.4 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application

7 China
7.1 China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2014-2019)
7.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Key Players in China
7.3 China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type
7.4 China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application

8 Japan
8.1 Japan Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2014-2019)
8.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Key Players in Japan
8.3 Japan Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type
8.4 Japan Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2014-2019)
9.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Key Players in Southeast Asia
9.3 Southeast Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type
9.4 Southeast Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application

10 India
10.1 India Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2014-2019)
10.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Key Players in India
10.3 India Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type
10.4 India Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application

11 Central & South America
11.1 Central & South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2014-2019)
11.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Key Players in Central & South America
11.3 Central & South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type
11.4 Central & South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application

12 International Players Profiles
12.1 Bayer AG
12.1.1 Bayer AG Company Details
12.1.2 Company Description and Business Overview
12.1.3 Vascular Endothelial Growth Factor (VEGF) Inhibitors Introduction
12.1.4 Bayer AG Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2014-2019))
12.1.5 Bayer AG Recent Development
12.2 F. Hoffmann-La Roche Ltd.
12.2.1 F. Hoffmann-La Roche Ltd. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Vascular Endothelial Growth Factor (VEGF) Inhibitors Introduction
12.2.4 F. Hoffmann-La Roche Ltd. Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2014-2019)
12.2.5 F. Hoffmann-La Roche Ltd. Recent Development
12.3 Novartis AG
12.3.1 Novartis AG Company Details
12.3.2 Company Description and Business Overview
12.3.3 Vascular Endothelial Growth Factor (VEGF) Inhibitors Introduction
12.3.4 Novartis AG Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2014-2019)
12.3.5 Novartis AG Recent Development
12.4 Regeneron Pharmaceuticals Inc.
12.4.1 Regeneron Pharmaceuticals Inc. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Vascular Endothelial Growth Factor (VEGF) Inhibitors Introduction
12.4.4 Regeneron Pharmaceuticals Inc. Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2014-2019)
12.4.5 Regeneron Pharmaceuticals Inc. Recent Development
12.5 Sanofi.
12.5.1 Sanofi. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Vascular Endothelial Growth Factor (VEGF) Inhibitors Introduction
12.5.4 Sanofi. Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2014-2019)
12.5.5 Sanofi. Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Vascular Endothelial Growth Factor (VEGF) Inhibitors Key Market Segments
Table Key Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Covered
Table Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer VEGF-A Inhibitor Figures
Table Key Players of VEGF-A Inhibitor
Figuer VEGF-B Inhibitor Figures
Table Key Players of VEGF-B Inhibitor
Figuer VEGF-C Inhibitor Figures
Table Key Players of VEGF-C Inhibitor
Figuer VEGF-D Inhibitor Figures
Table Key Players of VEGF-D Inhibitor
Table Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application in 2018 & 2025
Figure Oncology Case Studies
Figure Ophthalmology Case Studies
Figure Vascular Endothelial Growth Factor (VEGF) Inhibitors Report Years Considered
Figure Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Regions 2019-2025 (Million US$)
Table Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Regions 2019-2025 (Million US$)
Table Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Regions 2014-2019
Figure Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Regions 2014-2019
Figure Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue by by Players (2014-2019) (Million US$)
Table Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by by Players (2014-2019)
Figure Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by by Players in 2018
Table Global Vascular Endothelial Growth Factor (VEGF) Inhibitors by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Product/Solution/Service
Table Date of Enter into Vascular Endothelial Growth Factor (VEGF) Inhibitors Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2014-2019) (Million US$)
Table Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Share by Type (2014-2019)
Figure Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Type (2014-2019)
Table Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2014-2019) (Million US$)
Table Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Share by Application (2014-2019)
Figure Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Application (2014-2019)
Figure Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by Application in 2018
Figure North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2014-2019 (Million US$)
Table North America Key Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue (2018-2019) (Million US$)
Table North America Key Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share (2018-2019)
Table North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type 2014-2019 (Million US$)
Table North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type 2014-2019
Table North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application 2014-2019 (Million US$)
Table North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application 2014-2019
Figure Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2014-2019 (Million US$)
Table Europe Key Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue (2018-2019) (Million US$)
Table Europe Key Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share (2018-2019)
Table Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type 2014-2019 (Million US$)
Table Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type 2014-2019
Table Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application 2014-2019 (Million US$)
Table Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application 2014-2019
Figure China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2014-2019 (Million US$)
Table China Key Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue (2018-2019) (Million US$)
Table China Key Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share (2018-2019)
Table China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type 2014-2019 (Million US$)
Table China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type 2014-2019
Table China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application 2014-2019 (Million US$)
Table China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application 2014-2019
Figure Japan Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2014-2019 (Million US$)
Table Japan Key Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue (2018-2019) (Million US$)
Table Japan Key Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share (2018-2019)
Table Japan Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type 2014-2019 (Million US$)
Table Japan Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type 2014-2019
Table Japan Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application 2014-2019 (Million US$)
Table Japan Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application 2014-2019
Figure Southeast Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share (2018-2019)
Table Southeast Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type 2014-2019
Table Southeast Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application 2014-2019
Figure India Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2014-2019 (Million US$)
Table India Key Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue (2018-2019) (Million US$)
Table India Key Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share (2018-2019)
Table India Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type 2014-2019 (Million US$)
Table India Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type 2014-2019
Table India Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application 2014-2019 (Million US$)
Table India Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application 2014-2019
Figure Central & South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share (2018-2019)
Table Central & South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type 2014-2019 (Million US$)
Table Central & South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type 2014-2019
Table Central & South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application 2014-2019 (Million US$)
Table Central & South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application 2014-2019
Table Bayer AG Company Details
Table Bayer AG Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business 2014-2019 (Million US$)
Figure Bayer AG Revenue Growth Rate in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2014-2019)
Table Bayer AG Recent Development
Table F. Hoffmann-La Roche Ltd. Company Details
Table F. Hoffmann-La Roche Ltd. Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business 2014-2019 (Million US$)
Figure F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2014-2019)
Table F. Hoffmann-La Roche Ltd. Recent Development
Table Novartis AG Company Details
Table Novartis AG Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business 2014-2019 (Million US$)
Figure Novartis AG Revenue Growth Rate in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2014-2019)
Table Novartis AG Recent Development
Table Regeneron Pharmaceuticals Inc. Company Details
Table Regeneron Pharmaceuticals Inc. Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business 2014-2019 (Million US$)
Figure Regeneron Pharmaceuticals Inc. Revenue Growth Rate in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2014-2019)
Table Regeneron Pharmaceuticals Inc. Recent Development
Table Sanofi. Company Details
Table Sanofi. Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business 2014-2019 (Million US$)
Figure Sanofi. Revenue Growth Rate in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2014-2019)
Table Sanofi. Recent Development
Table Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Regions (Million US$) 2019-2025
Figure Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Share by Regions (2019-2025)
Figure Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Share by Regions in 2025
Figure North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure Japan Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure India Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast (2019-2025)(Million USD)
Table Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Product (2019-2025) (Million US$)
Figure Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Product (2019-2025)
Figure Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Product in 2025
Table Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2019-2025) (Million US$)
Figure Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2019-2025)
Figure Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size, Status and Forecast 2019-2025
QYR9NV18526 2019年11月18日 91Pages
※当調査レポートでは、血管内皮増殖因子(VEGF)阻害剤の世界市場について調査・分析し、血管内皮増殖因子(VEGF)阻害剤の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（VEGF-A阻害剤、VEGF...

BCL-2（B細胞リンパ腫2）阻害剤のグローバル市場：規模・現状・予測2019-2025

Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, Status and Forecast 2019-2025
QYR9NV17679 2019年11月18日 93Pages
※当調査レポートでは、BCL-2（B細胞リンパ腫2）阻害剤の世界市場について調査・分析し、BCL-2（B細胞リンパ腫2）阻害剤の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（併用療法、単剤療法）、用...

BCL-2（B細胞リンパ腫2）阻害剤のグローバル市場：規模・現状・予測2019-2025

PARP（ポリADPリボースポリメラーゼ）阻害剤のグローバル市場：規模・現状・予測2019-2025

Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size, Status and Forecast 2019-2025
QYR9NV18254 2019年11月18日 92Pages
※当調査レポートでは、PARP（ポリADPリボースポリメラーゼ）阻害剤の世界市場について調査・分析し、PARP（ポリADPリボースポリメラーゼ）阻害剤の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（...

PARP（ポリADPリボースポリメラーゼ）阻害剤のグローバル市場：規模・現状・予測2019-2025

多要素認証技術のグローバル市場：規模・現状・予測2019-2025

Global Multi-factor Authentication Technology Market Size, Status and Forecast 2019-2025
QYR9NV18188 2019年11月18日 95Pages
※当調査レポートでは、多要素認証技術の世界市場について調査・分析し、多要素認証技術の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（2因子、3因子、4因子、5因子）、用途別（医療、金融機関、政府、エン...

多要素認証技術のグローバル市場：規模・現状・予測2019-2025

腫瘍壊死因子(TNF)阻害薬のグローバル市場：規模・現状・予測2019-2025

Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, Status and Forecast 2019-2025
QYR9NV18509 2019年11月18日 93Pages
※当調査レポートでは、腫瘍壊死因子(TNF)阻害薬の世界市場について調査・分析し、腫瘍壊死因子(TNF)阻害薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ヒュミラ、エンブレル、レミケード、シンポ...

血管内皮増殖因子(VEGF)阻害剤のグローバル市場：規模・現状・予測2019-2025 Vascular endothelial growth factor inhibitors, also known as angiogenesis inhibitors, can prevent the generation of new blood vessels. The vascular endothelial growth factor is a protein that can trigger endothelial cells or pre-existing vessels to form new blood vessels. However, overexpression of …
世界及び中国の血管内皮成長因子阻害薬市場2018 The 'Global and Chinese Vascular Endothelial Growth Factor Inhibitor Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Vascular Endothelial Growth Factor Inhibitor industry with a focus on the Chinese market. The report provides key s…
世界及び中国の血管内皮細胞増殖因子受容体市場2018 The 'Global and Chinese Vascular Endothelial Growth Factor Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Vascular Endothelial Growth Factor industry with a focus on the Chinese market. The report provides key statistics on the mar…
腫瘍壊死因子(TNF)阻害薬のグローバル市場：規模・現状・予測2019-2025 A TNF inhibitor is a pharmaceutical drug that suppresses the physiologic response to tumor necrosis factor (TNF), which is part of the inflammatory response. TNF is involved in autoimmune and immune-mediated disorders such as rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel disease, …
腫瘍壊死因子(TNF)阻害薬のグローバル市場：規模・現状・予測2019-2025 A TNF inhibitor is a pharmaceutical drug that suppresses the physiologic response to tumor necrosis factor (TNF), which is part of the inflammatory response. TNF is involved in autoimmune and immune-mediated disorders such as rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel disease, …